BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 21423581)

  • 1. Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.
    Fugh-Berman A; McDonald CP; Bell AM; Bethards EC; Scialli AR
    PLoS Med; 2011 Mar; 8(3):e1000425. PubMed ID: 21423581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
    Chlebowski RT; Aragaki AK
    Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
    Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
    Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative.
    Majumdar SR; Almasi EA; Stafford RS
    JAMA; 2004 Oct; 292(16):1983-8. PubMed ID: 15507584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination.
    Wegienka G; Havstad S; Kelsey JL
    J Womens Health (Larchmt); 2006 May; 15(4):369-78. PubMed ID: 16724885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
    Lukes A
    J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
    Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
    Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.
    Harman SM; Vittinghoff E; Brinton EA; Budoff MJ; Cedars MI; Lobo RA; Merriam GR; Miller VM; Naftolin F; Pal L; Santoro N; Taylor HS; Black DM
    Am J Med; 2011 Mar; 124(3):199-205. PubMed ID: 21396500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The WHI ten year's later: an epidemiologist's view.
    Lacey JV
    J Steroid Biochem Mol Biol; 2014 Jul; 142():12-5. PubMed ID: 24029430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians' and women's views on hormone therapy and breast cancer risk after the WHI: a qualitative study.
    Nekhlyudov L; Bush T; Bonomi AE; Ludman EJ; Newton KM
    Women Health; 2009 Jun; 49(4):280-93. PubMed ID: 19753504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy: evolving concepts.
    Hendrix SL
    Curr Opin Rheumatol; 2003 Jul; 15(4):464-8. PubMed ID: 12819476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.